{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "L",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EGFR L858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The EGFR pathway is known to be involved in the development and progression of NSCLC, particularly in cases with activating mutations such as L858R.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "We used an enzyme-linked immunosorbent assay (ELISA) to measure EGFR kinase activity in cell lysates.",
      "judgment": "Yes"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The functional assay used in this paper demonstrates a very strong association between EGFR L858R mutation and increased kinase activity, supporting its classification as pathogenic."
}